Yang Ying, Ye Qiang, Li Kang, Li Zongwei, Bo Xiaochen, Li Zhen, Xu Yingchun, Wang Shengqi, Wang Peng, Chen Huipeng, Wang Junzhi
Academy of Military Medical SciencesBeijing, China.
Department of Biotechnology, Beijing Institute of Radiation MedicineBeijing, China.
Front Cell Infect Microbiol. 2017 Mar 31;7:105. doi: 10.3389/fcimb.2017.00105. eCollection 2017.
Over the last 50 years, newly described species of -like fungi have been implicated globally as sources of systemic human mycosis (emmonsiosis). Their ability to convert into yeast-like cells capable of replication and extra-pulmonary dissemination during the course of infection differentiates them from classical species. Immunocompromised patients are at highest risk of emmonsiosis and exhibit high mortality rates. In order to investigate the molecular basis for pathogenicity of the newly described species, genomic sequencing and comparative genomic analyses of sp. 5z489, which was isolated from a non-deliberately immunosuppressed diabetic patient in China and represents a novel seventh isolate of -like fungi, was performed. The genome size of 5z489 was 35.5 Mbp in length, which is ~5 Mbp larger than other strains. Further, 9,188 protein genes were predicted in the 5z489 genome and 16% of the assembly was identified as repetitive elements, which is the largest abundance in species. Phylogenetic analyses based on whole genome data classified 5z489 and CAC-2015a, another novel isolate, as members of the genus . Our analyses showed that divergences among occurred much earlier than other genera within the family Ajellomycetaceae, suggesting relatively distant evolutionary relationships among the genus. Through comparisons of species, we discovered significant pathogenicity characteristics within the genus as well as putative virulence factors that may play a role in the infection and pathogenicity of the novel strains. Moreover, our analyses revealed a novel distribution mode of DNA methylation patterns across the genome of 5z489, with >50% of methylated bases located in intergenic regions. These methylation patterns differ considerably from other reported fungi, where most methylation occurs in repetitive loci. It is unclear if this difference is related to physiological adaptations of new , but this question warrants further investigation. Overall, our analyses provide a framework from which to further study the evolutionary dynamics of strains and identity the underlying molecular mechanisms that determine the infectious and pathogenic potency of these fungal pathogens, and also provide insight into potential targets for therapeutic intervention of emmonsiosis and further research.
在过去50年里,新描述的类真菌物种在全球范围内被认为是人类系统性真菌病(埃蒙斯真菌病)的来源。它们在感染过程中转化为能够复制和肺外播散的酵母样细胞的能力,使它们有别于经典的物种。免疫功能低下的患者患埃蒙斯真菌病的风险最高,且死亡率很高。为了研究新描述的物种的致病分子基础,对从中国一名非故意免疫抑制的糖尿病患者中分离出的5z489菌株进行了基因组测序和比较基因组分析,该菌株代表了一种新的第七株类真菌。5z489的基因组大小为35.5兆碱基对,比其他菌株大约5兆碱基对。此外,在5z489基因组中预测有9188个蛋白质基因,且组装序列的16%被鉴定为重复元件,这在物种中是丰度最高的。基于全基因组数据的系统发育分析将5z489和另一个新分离株CAC - 2015a归类为属的成员。我们的分析表明,属内的分歧比阿耶洛菌科内的其他属早得多,这表明该属内的进化关系相对较远。通过对物种的比较,我们在该属内发现了显著的致病特征以及可能在新菌株的感染和致病性中起作用的假定毒力因子。此外,我们的分析揭示了5z489基因组中DNA甲基化模式的一种新分布模式,超过50%的甲基化碱基位于基因间区域。这些甲基化模式与其他报道的真菌有很大不同,其他真菌的甲基化大多发生在重复位点。目前尚不清楚这种差异是否与新物种的生理适应有关,但这个问题值得进一步研究。总体而言,我们的分析提供了一个框架,可据此进一步研究菌株的进化动态,并确定决定这些真菌病原体感染和致病能力的潜在分子机制,同时也为埃蒙斯真菌病的治疗干预潜在靶点及进一步研究提供了见解。